e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Clinical parameters in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation
S. Ion Gabriel, A. Teodorescu, D. Iulian Dan, A. Maria (Bucharest, Campulung Muscel, Galati, Romania)
Source:
Annual Congress 2011 - Clinical parameters in airway diseases
Session:
Clinical parameters in airway diseases
Session type:
Thematic Poster Session
Number:
949
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ion Gabriel, A. Teodorescu, D. Iulian Dan, A. Maria (Bucharest, Campulung Muscel, Galati, Romania). Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation. Eur Respir J 2011; 38: Suppl. 55, 949
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
COPD comorbidities – Do they add more cost? A 1-year follow-up study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Symptoms experienced by COPD patients during exacerbations and their association with healthcare utilization – EXACO study
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Multidimensional problem assessment of asthma and COPD in an older population: patient – physician concordance
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009
Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Psychological comorbidities in patients with COPD: Which changes can be observed after 3, 6, 9 and 12 months of an inpatient pulmonary rehabilitation (PR)?
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Chronic lung disease of prematurity: 10 years follow-up using clinical parameters and MR imaging – initial results
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Poorer quality of life in asthma patients is associated with rhinosinusitis, smoking and decreased lung function – Results from the Swedish GA
2
LEN survey
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Cognitive function of patients with COPD after virtual admission – A randomized clinical trial
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Outcomes in patients with COPD during a 3 year follow-up
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Managing asthma in the outpatient clinic – Can the FEV1/FVC indicate when to do a reversibility test?
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012
Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017
Stability of severe asthma phenotype – 1 year follow up BIOAIR study
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010
Breathlessness on bending down in COPD patients – prevalence and predictors
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Predictors of PAO
2
and PaCO
2
in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
The journey to severe obstructive lung disease – Retrospective study of FEV1 decline
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept